Gainers
- Biomerica BMRA shares rose 222.8% to $1.13 during Thursday's pre-market session. The market value of their outstanding shares is at $19.0 million. As per the news, the Q2 earnings report came out 2 days ago.
- Aditxt ADTX stock moved upwards by 53.51% to $0.2. The company's market cap stands at $2.8 million.
- Surrozen SRZN shares increased by 20.84% to $14.32. The market value of their outstanding shares is at $46.5 million.
- Traws Pharma TRAW shares increased by 13.78% to $7.8. The company's market cap stands at $23.5 million.
- Aclarion ACON shares moved upwards by 12.0% to $0.05.
- Enanta Pharma ENTA shares rose 10.05% to $5.3. The company's market cap stands at $112.4 million.
Losers
- Atara Biotherapeutics ATRA stock decreased by 50.5% to $6.52 during Thursday's pre-market session. The market value of their outstanding shares is at $37.5 million.
- Silexion Therapeutics SLXN shares fell 21.8% to $1.22. The company's market cap stands at $1.9 million.
- GlucoTrack GCTK stock decreased by 14.56% to $0.07. The market value of their outstanding shares is at $1.0 million.
- ArriVent BioPharma AVBP stock fell 11.68% to $22.01. The company's market cap stands at $741.6 million.
- Helius Medical Tech HSDT shares fell 10.95% to $0.76. The market value of their outstanding shares is at $2.8 million.
- Tenax Therapeutics TENX stock fell 10.5% to $5.8. The market value of their outstanding shares is at $19.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
ADTXAditxt Inc
$0.13744.89%
ATRAAtara Biotherapeutics Inc
$7.80-40.7%
AVBPArriVent BioPharma Inc
$24.63-1.16%
BMRABiomerica Inc
$0.7009100.3%
ENTAEnanta Pharmaceuticals Inc
$4.942.49%
GCTKGlucoTrack Inc
$0.0730-7.59%
HSDTHelius Medical Technologies Inc
$0.7850-7.65%
SLXNSilexion Therapeutics Corp
$0.9517-39.0%
SRZNSurrozen Inc
$12.334.05%
TENXTenax Therapeutics Inc
$6.41-1.16%
TRAWTraws Pharma Inc
$6.890.51%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in